普睿思 Praexisio Taiwan Inc.

普睿思 Praexisio Taiwan Inc. is a leading technology provider in the bioinformatics sector, dedicated to tackling critical pharmaceutical and societal challenges. Specializing in personalized drug design techniques, 普睿思 Praexisio Taiwan Inc. utilizes Next-Generation Sequencing (NGS), cMAP, AI assistance, and protein molecular dynamics simulations to achieve precise disease treatment and improve clinical trial outcomes.

Located at 新竹市東區光復路二段101號 新育成中心602室 Hsinchu, TW, 普睿思 Praexisio Taiwan Inc. is committed to enhancing the success rate and cost-effectiveness of drug development through state-of-the-art bioinformatics technology. The company has developed an automated system for interpreting disease genes using NGS, which improves the accuracy of diagnosing complex diseases and enables precise medication strategies. Additionally, their development of a high-performance computing manager, queuing system, and privacy-preserving similarity comparison software boosts work efficiency and ensures high-quality research.

普睿思 Praexisio Taiwan Inc. aspires to be the most reputable and professional integrated bioinformatics consulting service company, providing clients with accurate problem analysis and effective solutions. 普睿思 Praexisio Taiwan Inc. upholds rigorous scientific principles and intellectual property rights protection to help clients maximize their benefits. To discover more and explore potential collaborations, we invite the manager of 普睿思 Praexisio Taiwan Inc. to create a customized and exclusive company showcase and product listing on our platform.